Epilepsy triggered by mefloquine in an adult traveler to Uganda.

Author: AnghebenAndrea, BisoffiZeno, BuonfrateDora, GobbiFederico, PostiglioneChiara, RossaneseAndrea

Paper Details 
Original Abstract of the Article :
We report a case of a traveler who visited Uganda for 8 d, and took mefloquine one tablet/week for malaria prophylaxis. After the second dose, he suffered from two episodes of loss of consciousness with seizures, therefore mefloquine was discontinued. During the flight back after full recovery, seiz...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920231/

データ提供:米国国立医学図書館(NLM)

Mefloquine: A Traveler's Cautionary Tale

Travelers venturing into exotic destinations often face the risk of contracting malaria, a potentially life-threatening disease. Mefloquine, a widely used antimalarial medication, offers protection against this mosquito-borne illness. However, like a treacherous sandstorm in the desert, mefloquine can also cause unexpected side effects. This case report, like a traveler's diary, details the experience of an individual who developed epilepsy after taking mefloquine for malaria prophylaxis.

The Price of Protection: Epilepsy as a Side Effect

The case report describes a traveler who developed seizures after taking mefloquine for malaria prophylaxis. The seizures persisted even after mefloquine was discontinued, highlighting the potential for long-term neurological complications associated with this medication. This case serves as a stark reminder that even seemingly safe medications can have unforeseen consequences, and careful consideration of potential risks is crucial.

Navigating Malaria Prevention: Choosing the Right Path

The case report underscores the importance of weighing the risks and benefits of different malaria prevention strategies. While mefloquine is effective, it carries a higher risk of neurological side effects compared to alternative medications like atovaquone/proguanil and doxycycline. Travelers should consult with healthcare professionals to determine the most appropriate malaria prophylaxis regimen based on their individual needs and travel plans.

Dr.Camel's Conclusion

This case report, like a warning sign in the desert, reminds us of the importance of being aware of potential risks associated with medications. While mefloquine can provide valuable protection against malaria, it's crucial to weigh its benefits against the potential for neurological side effects. Travelers should choose their path carefully, consulting with healthcare professionals to navigate the complexities of malaria prevention.

Date :
  1. Date Completed 2014-02-14
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24527427

DOI: Digital Object Identifier

PMC3920231

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.